Skip to Main Content

Advertisement

Skip Nav Destination

Issues

Highlights

Commentary

Reviews

Research Articles

Sara Lindström; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Hilary Finucane; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Brendan Bulik-Sullivan; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Fredrick R. Schumacher; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Christopher I. Amos; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Rayjean J. Hung; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Kristin Rand; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Stephen B. Gruber; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; David Conti; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Jennifer B. Permuth; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Hui-Yi Lin; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Ellen L. Goode; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Thomas A. Sellers; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Laufey T. Amundadottir; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Rachael Stolzenberg-Solomon; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Alison Klein; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Gloria Petersen; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Harvey Risch; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Brian Wolpin; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Li Hsu; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Jeroen R. Huyghe; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Jenny Chang-Claude; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Andrew Chan; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Sonja Berndt; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Rosalind Eeles; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Douglas Easton; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Christopher A. Haiman; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; David J. Hunter; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Benjamin Neale; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Alkes L. Price; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO; Peter Kraft; on behalf of PanScan, GECCO and the GAME-ON Network: CORECT, DRIVE, ELLIPSE, FOCI, and TRICL-ILCCO

Null Results in Brief

Author Choice
Albina N. Minlikeeva; on behalf of the Ovarian Cancer Association Consortium; Jo L. Freudenheim; on behalf of the Ovarian Cancer Association Consortium; Kevin H. Eng; on behalf of the Ovarian Cancer Association Consortium; Rikki A. Cannioto; on behalf of the Ovarian Cancer Association Consortium; Grace Friel; on behalf of the Ovarian Cancer Association Consortium; J. Brian Szender; on behalf of the Ovarian Cancer Association Consortium; Brahm Segal; on behalf of the Ovarian Cancer Association Consortium; Kunle Odunsi; on behalf of the Ovarian Cancer Association Consortium; Paul Mayor; on behalf of the Ovarian Cancer Association Consortium; Brenda Diergaarde; on behalf of the Ovarian Cancer Association Consortium; Emese Zsiros; on behalf of the Ovarian Cancer Association Consortium; Linda E. Kelemen; on behalf of the Ovarian Cancer Association Consortium; Martin Köbel; on behalf of the Ovarian Cancer Association Consortium; Helen Steed; on behalf of the Ovarian Cancer Association Consortium; Anna deFazio; on behalf of the Australian Ovarian Cancer Study Group; on behalf of the Ovarian Cancer Association Consortium; Susan J. Jordan; on behalf of the Ovarian Cancer Association Consortium; Peter A. Fasching; on behalf of the Ovarian Cancer Association Consortium; Matthias W. Beckmann; on behalf of the Ovarian Cancer Association Consortium; Harvey A. Risch; on behalf of the Ovarian Cancer Association Consortium; Mary Anne Rossing; on behalf of the Ovarian Cancer Association Consortium; Jennifer A. Doherty; on behalf of the Ovarian Cancer Association Consortium; Jenny Chang-Claude; on behalf of the Ovarian Cancer Association Consortium; Marc T. Goodman; on behalf of the Ovarian Cancer Association Consortium; Thilo Dörk; on behalf of the Ovarian Cancer Association Consortium; Robert Edwards; on behalf of the Ovarian Cancer Association Consortium; Francesmary Modugno; on behalf of the Ovarian Cancer Association Consortium; Roberta B. Ness; on behalf of the Ovarian Cancer Association Consortium; Keitaro Matsuo; on behalf of the Ovarian Cancer Association Consortium; Mika Mizuno; on behalf of the Ovarian Cancer Association Consortium; Beth Y. Karlan; on behalf of the Ovarian Cancer Association Consortium; Ellen L. Goode; on behalf of the Ovarian Cancer Association Consortium; Susanne K. Kjær; on behalf of the Ovarian Cancer Association Consortium; Estrid Høgdall; on behalf of the Ovarian Cancer Association Consortium; Joellen M. Schildkraut; on behalf of the Ovarian Cancer Association Consortium; Kathryn L. Terry; on behalf of the Ovarian Cancer Association Consortium; Daniel W. Cramer; on behalf of the Ovarian Cancer Association Consortium; Elisa V. Bandera; on behalf of the Ovarian Cancer Association Consortium; Lisa E. Paddock; on behalf of the Ovarian Cancer Association Consortium; Lambertus A. Kiemeney; on behalf of the Ovarian Cancer Association Consortium; Leon F.A.G. Massuger; on behalf of the Ovarian Cancer Association Consortium; Rebecca Sutphen; on behalf of the Ovarian Cancer Association Consortium; Hoda Anton-Culver; on behalf of the Ovarian Cancer Association Consortium; Argyrios Ziogas; on behalf of the Ovarian Cancer Association Consortium; Usha Menon; on behalf of the Ovarian Cancer Association Consortium; Simon A. Gayther; on behalf of the Ovarian Cancer Association Consortium; Susan J. Ramus; on behalf of the Ovarian Cancer Association Consortium; Aleksandra Gentry-Maharaj; on behalf of the Ovarian Cancer Association Consortium; Celeste L. Pearce; on behalf of the Ovarian Cancer Association Consortium; Anna H. Wu; on behalf of the Ovarian Cancer Association Consortium; Jolanta Kupryjanczyk; on behalf of the Ovarian Cancer Association Consortium; Allan Jensen; on behalf of the Ovarian Cancer Association Consortium; Penelope M. Webb; on behalf of the Ovarian Cancer Association Consortium; Kirsten B. Moysich; on behalf of the Ovarian Cancer Association Consortium

Letter to the Editor

Close Modal

or Create an Account

Close Modal
Close Modal